Medicare Compliance & Reimbursement

Home Care:

OIG OKs Copay Waiver On Diabetes Supplies

Follow these top attorneys' tips to make sure your copay waivers are legit.

Home care providers and durable medical equipment suppliers need to get a handle on waivers of copayments for DME.

The HHS Office of Inspector General has given its stamp of approval to a plan to waive Medicare copayments for glucose testing equipment and supplies, according to an OIG advisory opinion issued Feb. 9 (No. 04-01). The proposed scenario covers 2,800 patients treated at 40 clinical centers.

The patients are expected to participate in a government study on the best medical approaches for addressing coronary artery disease in patients with Type II diabetes. The study's protocol would require the patients to self-monitor their blood glucose levels.

The anonymous requester of the opinion sought the OIG's blessing for waiver of the copayments for the equipment and supplies needed for the self-monitoring - and it was successful.

The OIG OK'd the usually taboo waivers partially  because the study was government-sponsored and controlled, it says in the opinion. Government control minimizes the OIG's usual fraud and abuse concerns, says attorney John Wester with Sidley Austin Brown & Wood in Washington, DC.

And the OIG liked the fact that the clinical trial involved is not oriented to a commercial product. Instead, the study seeks to determine best medical practices. "Some studies are more about trying to get referrals rather than a scientific purpose," notes attorney Robert Falk with Powell Goldstein Frazer & Murphy in Washington, DC. The Right - and Wrong - Way To Waive Copays But this opinion is so narrowly tailored that it is unlikely to help suppliers struggling with their day-to-day confusion about when to waive copays, Falk says.

Suppliers get hit from both sides on the copay issue, he maintains. Consumer groups and even legislators complain when health care providers collect copays too aggressively from elderly and fragile patients. But the feds come down hard on suppliers who appear to be offering kickbacks through routine waivers of the cost-sharing mechanism.

Attorneys offer the following tips for staying on the right side of the law but still making sure needy patients who require supplies and equipment can get them: Don't routinely waive copayments. No matter how tempting it is, waiving copays on a blanket basis is a major no-no in the feds' book. Make case-by-case decisions. That doesn't mean you can't ever waive copays. "Suppliers may waive copays based on an individualized determination of financial hardship or indigence for each patient," Wester counsels. But make sure it really is an individual, well-researched decision. Set eligibility guidelines. There is a marked lack of guidance in the area of copays, Falk protests. "It's a whole unresolved issue." While suppliers wait on official guidelines, they can set their own standards for copayment eligibility, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.